- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.10. | SOD SCIENCES INC.: SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test | 658 | ACCESS Newswire | VERO BEACH, FL / ACCESS Newswire / October 29, 2026 / SOD Sciences, Inc. ("SOD Sciences" or "SOD") today announced the closing of its strategic partnership with Vivo Therapeutics, Inc. (Nasdaq:VVOS)... ► Artikel lesen | |
| 21.10. | Vivos Therapeutics reports Nasdaq compliance confirmation with continued listing shareholders' equity standard | 5 | Seeking Alpha | ||
| 19.10. | Vivos Therapeutics acquires stake in SOD Sciences | 1 | Investing.com | ||
| 19.10. | Vivos Therapeutics erwirbt Beteiligung an SOD Sciences | 1 | Investing.com Deutsch | ||
| 19.10. | Vivos Therapeutics, Inc: Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel | 1 | GlobeNewswire (USA) | ||
| 15.10. | Vivos Therapeutics to acquire minority stake in SOD Sciences in $12M stock transaction | 2 | Seeking Alpha | ||
| 15.10. | Vivos Therapeutics, Inc: Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test | 1 | GlobeNewswire (USA) | ||
| VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 15.10. | Vivos Therapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 01.10. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 29.09. | Vivos Therapeutics plant jährliche Kostensenkungen von 3,6 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 29.09. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives | 270 | GlobeNewswire (Europe) | LITTLETON, Colo., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the Company") (Nasdaq: VVOS), a medical device and healthcare services company focused on developing and... ► Artikel lesen | |
| 01.09. | Vivos Therapeutics, Inc.: Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference | 843 | Newsfile | Littleton, Colorado--(Newsfile Corp. - September 1, 2026) - Vivos Therapeutics, Inc. (NASDAQ: VVOS) ("Vivos" or the "Company"), a leading medical technology and healthcare services company focused on... ► Artikel lesen | |
| 28.08. | Vivos Therapeutics, Inc: Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center | 6 | GlobeNewswire (USA) | ||
| 25.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers | 1 | GlobeNewswire (USA) | ||
| 21.08. | Vivos Therapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 20.08. | Vivos Therapeutics opens Henderson facility with $10M capacity | 1 | Investing.com | ||
| 20.08. | Vivos Therapeutics, Inc: Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment | 1 | GlobeNewswire (USA) | ||
| 18.08. | Vivos Therapeutics: Service Revenue Nearly Doubles To $3.8 Million While Product Revenue Falls 28% | 4 | pulse2.com | ||
| 17.08. | Vivos Therapeutics GAAP EPS of -$0.31 misses by $0.01, revenue of $5.15M misses by $0.99M | 1 | Seeking Alpha | ||
| 15.08. | Vivos Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com |
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,730 | -0,65 % | Eckert&Ziegler erhält GMP-Zertifizierung: Warum der nächste Schub greifbar wird | ||
| TELADOC HEALTH | 7,920 | -1,17 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,067 | 0,00 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics |
EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| CERENOME | 0,508 | -12,41 % | Cerenome names Ron Andrews as chief business officer | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| CARDINAL HEALTH | 245,40 | -1,09 % | ROUNDUP: Cardinal Health Boosts FY26 Adj. EPS Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Thursday, healthcare services company Cardinal Health, Inc. (CAH) raised its adjusted earnings guidance for... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,950 | +1,04 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax | Total revenue increased 28% for the quarter and 41% for the six months ended September 30, 2026 compared to same periods last yearU.S. revenue increased 93% for the quarter and 113% for the six months... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| LIFESTANCE HEALTH GROUP | 14,550 | -0,07 % | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | ||
| GENEDX | 54,93 | +0,18 % | Why GeneDx Holdings Stock Just Dropped 16.6% | ||
| BRIGHTSPRING HEALTH SERVICES | 72,51 | +0,03 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 112,12 | 0,00 % | BTIG reiterates Buy on BillionToOne stock, keeps $130 target | ||
| BASEL MEDICAL GROUP | 1,900 | -1,55 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
Das Unternehmen VIVOS THERAPEUTICS INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,002 (+2,20 %) liegt der Kurs bei 0,088 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIVOS THERAPEUTICS INC finden Sie auf Wallstreet Online.